Patrick Vallance
Physician and former Minister of State for Science, Research and Innovation of the United Kingdom
3
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Oct 21, 2026
How does biological sex affect health?
21:35
21:45
21:51
A
21:29Alistair MorrisonAUDIENCE
What impact could this have on its use in the healthcare setting?
Patrick VallanceGUEST
We know that, of course, the AI algorithms are only as good as the data they train on.
Patrick VallanceGUEST
And we know there are areas like where AI is used for diagnosis of skin lesion.
Patrick VallanceGUEST
the AI is trained on white skin and doesn't perform as well on skins of different shades.
7 MINS LATER
How is AI transforming medicine?
29:00
29:08
Patrick VallanceGUEST
In the pandemic, it was possible to get vaccines very quickly because of the way that the new technologies had come along with messenger RNA and so on.
Patrick VallanceGUEST
Just a few weeks ago, groups were showing that you can use AI to predict how to make vaccines that won't just tackle one specific variant of a virus, but could actually broaden that to tackle a whole range, 'cause it could look at all of the possible ways in which that virus was going to mutate, and think about what the, um, immunogenic stimulus would look like that you'd have to go after with a vaccine.
P
32:41Peter BufferyAUDIENCE
Where do you see the role of AI in future du- drug discovery? How well can a model built in a digital world really translate into the biolo- biological environment where cellular activity is far messier and more complex than any, any existing model can fully capture?
Can The NHS Afford The UK-US Pharma Deal?
15:01
15:20
21:38
Steph McGovernHOST
And do you think that there are therefore areas in science and tech where we as the UK have a genuine competitive advantage, but we're under investing in it? Like, are there areas where we should be investing more because we are the leaders in it to get that commercial growth as well?
Patrick VallanceGUEST
I got a note actually from a well-known venture capitalist in the UK called Saul Klein.
6 MINS LATER
Robert PestonHOST
How do we provide a financial infrastructure That means that the maximum returns as these companies grow flow to the UK in terms of revenue, taxes, jobs, and the rest.